AbbVie, Inc. (ABBV)
262.82
+2.89
(+1.11%)
USD |
NYSE |
Oct 02, 16:00
263.85
+1.03
(+0.39%)
After-Hours: 20:00
AbbVie Gross Profit Margin (Quarterly) : 74.71% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.71% |
| March 31, 2026 | 71.93% |
| December 31, 2025 | 72.63% |
| September 30, 2025 | 66.12% |
| June 30, 2025 | 71.63% |
| March 31, 2025 | 70.00% |
| December 31, 2024 | 71.10% |
| September 30, 2024 | 71.00% |
| June 30, 2024 | 71.01% |
| March 31, 2024 | 66.84% |
| December 31, 2023 | 70.17% |
| September 30, 2023 | 68.84% |
| June 30, 2023 | 69.84% |
| March 31, 2023 | 73.07% |
| December 31, 2022 | 72.89% |
| September 30, 2022 | 71.60% |
| June 30, 2022 | 71.46% |
| March 31, 2022 | 70.24% |
| December 31, 2021 | 71.44% |
| September 30, 2021 | 69.91% |
| June 30, 2021 | 67.93% |
| March 31, 2021 | 67.87% |
| December 31, 2020 | 68.11% |
| September 30, 2020 | 60.91% |
| June 30, 2020 | 64.73% |
| Date | Value |
|---|---|
| March 31, 2020 | 77.47% |
| December 31, 2019 | 76.40% |
| September 30, 2019 | 76.86% |
| June 30, 2019 | 77.52% |
| March 31, 2019 | 77.85% |
| December 31, 2018 | 75.86% |
| September 30, 2018 | 78.38% |
| June 30, 2018 | 77.19% |
| March 31, 2018 | 76.27% |
| December 31, 2017 | 74.88% |
| September 30, 2017 | 76.35% |
| June 30, 2017 | 77.33% |
| March 31, 2017 | 75.02% |
| December 31, 2016 | 77.13% |
| September 30, 2016 | 76.59% |
| June 30, 2016 | 77.94% |
| March 31, 2016 | 77.66% |
| December 31, 2015 | 75.48% |
| September 30, 2015 | 78.87% |
| June 30, 2015 | 82.34% |
| March 31, 2015 | 80.87% |
| December 31, 2014 | 79.84% |
| September 30, 2014 | 79.40% |
| June 30, 2014 | 77.89% |
| March 31, 2014 | 76.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 61.37% |
| Gilead Sciences, Inc. | 79.81% |
| Amgen, Inc. | 72.08% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
| Johnson & Johnson | 68.73% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | 4.64% |
| Return on Invested Capital | 9.43% |
| Profit Margin (Quarterly) | 21.21% |
| Operating Margin (Quarterly) | 39.54% |
| Return on Net Operating Assets | 5.60% |